Molecular diagnostic firm Quanterix moves into oncology research with benchtop imager | FierceBiotech
Nov 20, 2018 @ 10:40

Quanterix is expanding its blood biomarker testing business into oncology, providing an early access program to its benchtop imager and a new 10-plex assay panel for cancer research and drug development.

Sourced through Scoop.it from: www.fiercebiotech.com

Leave a Reply